Idience Co., Ltd.
Clinical trials sponsored by Idience Co., Ltd., explained in plain language.
-
New drug shows promise for Hard-to-Treat cancers with specific gene flaw
Disease control CompletedThis study tested an experimental drug called IDX-1197 in 108 adults with solid tumors that have a specific gene change (HRR mutation) and who had no other good treatment options. The goal was to find the safest dose and see if the drug could shrink tumors. The trial was complete…
Phase: PHASE1, PHASE2 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug tested for advanced cancers: early results
Disease control CompletedThis early-phase trial tested a new drug called NOV140101 in 32 adults with advanced solid tumors that had spread or could not be removed by surgery. The main goals were to find the safest dose and check for side effects. The study is complete, but it was too small to determine i…
Phase: PHASE1 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC